13157735 · Active · incorporated 5 years, 6 months ago · Abingdon
Biotech Biotech & Life Sciences Drug Discovery Series B+
ThirtyFiveBio develops treatments for ulcerative colitis, focusing on a gut epithelial shield and small molecule inhibitors of GPR35.
https://www.thirtyfivebio.com/
See the complete cap table with every shareholder, founder tags, dilution across 14 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.